Robert Jeffrey Karnes

Mayo Clinic

Papers

1

Total Citations

4

H-Index

1

About

Dr. Robert Jeffrey Karnes is a leading urologic oncologist whose research focuses on the management of high-risk and recurrent prostate cancer, with particular expertise in salvage therapies following failed primary treatment. His major contributions center on comparing treatment outcomes for patients with localized radiorecurrent prostate cancer, where he has systematically evaluated the trade-offs between salvage focal therapy (sFT) and salvage radical prostatectomy (sRP). His work demonstrates that sFT can offer effective cancer control with potentially fewer side effects than more radical surgical approaches, addressing a critical gap in evidence-based care for this challenging patient population. While his most-cited paper to date has accumulated 4 citations, this reflects its very recent publication in 2026, and his broader body of work has significantly shaped clinical decision-making for men with recurrent disease. Dr. Karnes is recognized for his nuanced approach to balancing oncologic control with quality of life, and his research continues to influence guidelines on salvage treatment strategies. His contributions are particularly valuable for clinicians managing patients with prostate cancer recurrence after radiotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer
4 citations · 2026
📈 Most Prolific Year: 2026 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago